Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V99.9.3263PMID 11964292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferons, a group of multiple lymphokines

  2004cited by this paper
• Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

  2001cited by this paper
• Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

  2001cited by this paper
• IFN-gamma production by antigen-presenting cells: mechanisms emerge.

  2001cited by this paper
• Differential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets1

  2001cited by this paper
• IFN-γ production by antigen-presenting cells: mechanisms emerge

  2001cited by this paper
• Interferon-α and -β inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14+ precursors

  2000cited by this paper
• The control of T cell responses by dendritic cell subsets.

  2000cited by this paper
• Consequences of Cell Death

  2000cited by this paper
• Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

  2000cited by this paper
• Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

  2000cited by this paper
• The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor

  2000cited by this paper
• The function of type I interferons in antimicrobial immunity.

  2000cited by this paper
• Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity

  2000cited by this paper
• Oligosaccharides of Hyaluronan Are Potent Activators of Dendritic Cells1

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Consequences of cell death: exposure to necrotic tumor cells

  2000cited by this paper
• Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo

  2000cited by this paper
• Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors.

  2000cited by this paper
• Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression.

  2000cited by this paper
• Natural adjuvants: Endogenous activators of dendritic cells

  1999cited by this paper
• Low Levels of Interferon‐α Induce CD86 (B7.2) Expression and Accelerates Dendritic Cell Maturation from Human Peripheral Blood Mononuclear Cells

  1999cited by this paper
• Virus interactions with dendritic cells.

  1999cited by this paper
• An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

  1999cited by this paper
• Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.

  1999cited by this paper
• The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business

  1999cited by this paper
• T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

  1999cited by this paper
• Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA

  1999cited by this paper
• Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

  1999cited by this paper
• The nature of the principal type 1 interferon-producing cells in human blood.

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

  1999cited by this paper
• Natural killer cells in antiviral defense: function and regulation by innate cytokines.

  1999cited by this paper
• Coordinated events during bacteria-induced DC maturation.

  1999cited by this paper
• The role of dendritic cells in the induction and regulation of immunity to microbial infection.

  1999cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Type I IFNs enhance the terminal differentiation of dendritic cells.

  1998cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• The effects of DNA containing CpG motif on dendritic cells

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

  1998cited by this paper
• IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages.

  1997cited by this paper
• Production of Interferon‐α/β by Murine Dendritic Cell Lines Stimulated by Virus and Bacteria

  1997cited by this paper
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

  1996cited by this paper
• Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.

  1996cited by this paper
• A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis

  1996cited by this paper
• A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.

  1996cited by this paper
• Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

  1995cited by this paper
• Role of interferons and other cytokines in the regulation of the immune response

  1995cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Activation of human dendritic cells through CD40 cross-linking

  1994cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells

  1992cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

  1990cited by this paper
• Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice

  1988cited by this paper
• Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.

  1987cited by this paper
• Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon.

  1987cited by this paper
• Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages

  1985cited by this paper
• Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.

  1984cited by this paper
• Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing

  1983cited by this paper
• Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors

  1983cited by this paper
• Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

  1976cited by this paper
• Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

  1976cited by this paper
• A Method for the Large Scale Production of Potent Interferon Preparations

  1974cited by this paper

• Type I interferons in bacterial diseases: myeloid cells at the crossroads of protection and pathology

  2026cites this paper
• The differentiation and function of heterogeneous thymic dendritic cell subsets require signals provided by distinct thymocyte cell types

  2026cites this paper
• Single-cell sequencing-guided design of synergistic chemo-immunotherapy nanodrugs for cGAS-STING activation in prostate cancer therapy

  2026cites this paper
• The impact of STING signaling on myeloid cells highlights macrophages as the major player in controlling Brucella abortus

  2026cites this paper
• In vitro characterization of cellular responses elicited by endosomal TLR agonists encapsulated in Qβ virus-like particles

  2025cites this paper
• RAE1-armoured DC vaccine boosts NKG2D-CAR-T cells elicited anti-solid tumour treatment.

  2025cites this paper
• Coordinated changes in stromal and hematopoietic cells that define the perinatal to juvenile transition in the mouse thymus.

  2025cites this paper
• DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation

  2025cites this paper
• The potential immunomodulatory role of human milk oligosaccharides in prevention of viral infections and development of asthma in early life

  2025cites this paper
• A novel vaccination strategy induces vaccine-specific mucosal responses at port of viral entry and exit: using systemic SARS-CoV-2 vaccination as a test case

  2025cites this paper
• Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure

  2025cites this paper
• Protective Efficacy of Two Novel DNA Vaccine Candidates Encoding TgGRA28 and TgGRA83 with an IL-28B Molecular Adjuvant Against Acute and Chronic Toxoplasmosis in Mice

  2025cites this paper
• Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ

  2025cites this paper
• Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling

  2025cites this paper
• ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213

  2025cites this paper
• Flagellin and R-848 co-stimulation induces early synergistic and delayed attenuated immune responses in the chicken peripheral blood

  2025cites this paper
• Dendritic cell maturation in cancer

  2025cites this paper
• Effects of the Alkylating Agent Cyclophosphamide in Potentiating Anti-Tumor Immunity

  2025cites this paper
• Immunological properties of silica nanoparticles: a structure–activity relationship study

  2024cites this paper
• Downregulation of IRF7-mediated type-I interferon response by LmCen–/– parasites is necessary for protective immunity

  2024cites this paper
• Airway-resident memory CD4 T cell activation accelerates antigen presentation and T cell priming in draining lymph nodes

  2024cites this paper
• IFNs: Maestros of the Immune System.

  2024cites this paper
• In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

  2024cites this paper
• Inhibiting retinoic acid signaling in dendritic cells suppresses respiratory syncytial virus infection through enhanced antiviral immunity

  2024cites this paper
• Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway

  2024cites this paper
• Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections

  2024cites this paper
• Correlation analysis between peripheral blood dendritic cell subsets and PD-1 in patients with peritoneal adenocarcinoma

  2024cites this paper
• Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer

  2024cites this paper
• Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity

  2024cites this paper
• Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine

  2024cites this paper
• Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immunopathology

  2024cites this paper
• Human Immunodeficiency Virus–Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load

  2024cites this paper
• Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8+ T cell responses against an arthritogenic alphavirus

  2024cites this paper
• Interferon-Inhibition beim systemischen Lupus erythematodes

  2024cites this paper
• Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway

  2023cites this paper
• ISCOMs/MPLA-Adjuvanted SDAD Protein Nanoparticles Induce Improved Mucosal Immune Responses and Cross-Protection in Mice.

  2023cites this paper
• m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma

  2023influential citation
• “Just right” combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation

  2023cites this paper
• Nanovaccines: An effective therapeutic approach for cancer therapy.

  2023cites this paper
• Targeting type I interferons in systemic lupus erythematous

  2023cites this paper
• Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype

  2023cites this paper
• Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2

  2023cites this paper
• Dendritic cell subsets in cancer immunity and tumor antigen sensing

  2023cites this paper
• An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses

  2023cites this paper
• The role of dendritic cells in radiation-induced immune responses.

  2023cites this paper
• Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART

  2023cites this paper
• Targeting STING in cancer: Challenges and emerging opportunities.

  2023cites this paper
• The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest

  2023cites this paper
• Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response

  2023influential citation
• Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy

  2023influential citation
• Protective versus Pathogenic Type I Interferon Responses during Virus Infections

  2023cites this paper
• MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML

  2023cites this paper
• Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response

  2023cites this paper
• The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection

  2023cites this paper
• Exploiting innate immunity for cancer immunotherapy

  2023cites this paper
• Good cop, bad cop: Polyamines play both sides in host immunity and viral replication.

  2023cites this paper
• Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches

  2023cites this paper
• Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice

  2022cites this paper
• Excessive inflammatory response to infection in experimental peri‐implantitis: Resolution by Resolvin D2

  2022cites this paper
• Multiplexed Electrospray Enables High Throughput Production of cGAMP Microparticles to Serve as an Adjuvant for a Broadly Acting Influenza Vaccine.

  2022cites this paper
• Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier

  2022cites this paper
• IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis.

  2022cites this paper
• NK cells contribute to reovirus-induced IFN responses and loss of tolerance to dietary antigen

  2022cites this paper
• Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon‐stimulated genes signaling during pregnancy *

  2022cites this paper
• Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1

  2022cites this paper
• The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19

  2022cites this paper
• Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression

  2022cites this paper
• Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma

  2022cites this paper
• The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis

  2022cites this paper
• Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity

  2022cites this paper
• Contribution of Dendritic Cell Subsets to T Cell–Dependent Responses in Mice

  2022cites this paper
• Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects

  2022cites this paper
• Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities.

  2022cites this paper
• Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines

  2022cites this paper
• CD8+ T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy

  2022cites this paper
• Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer

  2022cites this paper
• Type I and II interferon signaling in colorectal cancer liver metastasis.

  2022cites this paper
• miR-aculous new avenues for cancer immunotherapy

  2022cites this paper
• Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation

  2022cites this paper
• Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer and Autoimmunity

  2022cites this paper
• Therapeutic agents against COVID-19 with clinical evidence.

  2021cites this paper
• Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy

  2021cites this paper
• Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect

  2021cites this paper
• Short-Chain Fatty Acids Calibrate RARα Activity Regulating Food Sensitization

  2021cites this paper
• Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease

  2021cites this paper
• Double-edged effects of interferons on the regulation of cancer-immunity cycle

  2021influential citation
• STING Agonists as Cancer Therapeutics

  2021cites this paper
• DCision-making in tumors governs T cell anti-tumor immunity

  2021cites this paper
• Efficient antigen cross-presentation through coating conventional aluminum adjuvant particles with PEI.

  2021cites this paper
• Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines

  2021cites this paper
• Type I and II Interferons in the Anti-Tumor Immune Response

  2021cites this paper
• The role of dendritic cells in cancer and anti-tumor immunity.

  2021cites this paper
• Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort

  2021cites this paper
• Type I interferons in pancreatic cancer and development of new therapeutic approaches.

  2020cites this paper
• Polymeric nanoparticle vaccines to combat emerging and pandemic threats

  2020cites this paper
• Type I Interferons Promote Germinal Centers Through B Cell Intrinsic Signaling and Dendritic Cell Dependent Th1 and Tfh Cell Lineages

  2020cites this paper
• Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse

  2020cites this paper
• A genetic variant controls interferon-β gene expression in human myeloid cells by preventing C/EBP-β binding on a conserved enhancer

  2020cites this paper
• Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γ as a Novel Antiviral Approach Against COVID-19

  2020cites this paper
• Parallels between the anti-Viral State and the Irradiated State.

  2020cites this paper